[2PL1]Tofacitinib (CP-690,550): A First-In-Class Janus Kinase (JAK) Inhibitor for the Treatment of Rheumatoid Arthritis
○Flanagan Mark E.(Pfizer Worldwide Medicinal Chemistry)
You can search for presentations in this event.
SearchYou can search for presentations in this event.
SearchSearch Results(2,716)
○Flanagan Mark E.(Pfizer Worldwide Medicinal Chemistry)
○Takahashi Yoshiko(Department of Zoology, Biological Science, Graduate School of Science, Kyoto University)
○Sakaguchi Shimon(Laboratory of Experimental Immunology, WPI Immunology Frontier Research Center, Osaka University)
○David Stewart
○Ronald McKay(The Lieber Institute for Brain Development, Baltimore, MD.)
○Deng Hongkui(Stem cell research Center, Peking University)
○Okano Hideyuki(Dep. of Physiol., Sch. of Med. ., Keio Univ)
○Xin-Yuan Fu(Cancer Science Institute and Dept of Biochemistry, National University of Singapore)
○Yamamoto Toshiyuki1, Shimojima Keiko1,2(1.TIIMS, Tkyo Women's Med Univ., 2.PRESTO, JST)
○Yoshida Yoshinori(Center for iPS cell Research and Application, Kyoto University)
○Inoue Haruhisa1,2(1.CiRA, Kyoto Univ., 2.JST CREST)
○Kaneko Shin(Shin Kaneko Lab., Dept. Cell Growth and Differentiation, CiRA, Kyoto Univ.)
○Era Takumi, Soga Minami, Hamasaki Makoto(Dept. of Cell Modulation, IMEG, Kumamoto Univ.)
○Kabashima Kenji(Department of Dermatology, Kyoto University, Japan)
○Taketomi Yoshitaka1, Murakami Makoto1,2(1.Lipid Metab. Proj., Tokyo Metr. Inst. Med. Sci., 2.CREST, JST)
○Miyasaka Masayuki1, Umemoto Eiji2, Takeda Akira2, Hata Erina2, Sasaki Naoko2(1.IPBS, IAI, Osaka University, 2.Immune Regulation, Osaka Univ. Grad. Sch. Med.)
○Yamasaki Sho(Div. of Mol. Immunol. Med. Inst. of Bioreg., Kyushu Univ.)
○Arita Makoto1,2,3(1.Lab. for Metabolomics, IMS, RIKEN, 2.Grad. Sch. of Med. Life Sci., Yokohama City Univ., 3.PRESTO, JST)
○Fukasawa Masayoshi(Dept. of Biochem. & Cell Biol., Natl. Inst. of Infect. Dis.)
○Kobayashi Toshihide(Lipid Biol Lab, RIKEN)
○Inokuchi Jin-ichi(Div. of Glycopathol., Inst. of Mol. Biomembrane and Glycobiology, Tohoku Phar,. Univ.)
kajimoto Taketoshi, Okada Taro, Miya Satoshi, Zhang Lifang,○Nakamura Shun-ichi(Div. of Biochem. Kobe Univ. Grad. School of Med.)
○Maeda Yusuke1,2, Kinoshita Taroh1,2, Okuzaki Daisuke3(1.Dept. of Immunoreg., RIMD., Osaka Univ., 2.Immunoglyco., iFReC., Osaka Univ., 3.DDCID., RIMD., Osaka Univ.)
○Yanagi Shigeru, Tokuyama Takeshi, Takeda Keisuke, Inatome Ryoko, Nagashima Shun(Lab. of Mol. Biochem., Sch. of Life Sci., Tokyo Univ. of Pharm. and Life Sci.)
○Bakker Hans, Shcherbakova Aleksandra, Buettner Falk FR, Tiemann Birgit(Dept. of Cellular Chemistry, Hannover Medical School, Germany)
○Harada Yoichiro, Suzuki Tadashi(Glycometabolome Team, Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center, Global Research Cluster, RIKEN)
○Kohda Daisuke(Div. of Struct. Biol., Med. Inst. of Bioreg., Kyushu Univ.)
○Satoh Tadashi1,2, Kato Koichi1,3(1.Grad. Sch. Pharm. Sci., Nagoya City Univ., 2.JST, PRESTO, 3.Okazaki Inst. Integ. Biosci.)
○Okajima Tetsuya, Ogawa Mitsutaka, Furukawa koichi(Nagoya Univ. Sch. of Med.)
○Chihara Takahiro1,2, Sekine Sayaka1, Moriya Hiroyuki1, Miura Masayuki1,2(1.Dept of Genetics, Grad Sch of Pharm Sci, The Univ. of Tokyo, Tokyo, Japan, 2.CREST, JST)
○Fujiki Yukio, Itoyama Akinori, Abe Yuichi, Honsho Masanori(Dept. of Biology, Faculty of Sciences, Kyushu University Graduate School)
○Tamura Yasushi1, Endo Toshiya2(1.RCMS, Nagoya Univ., 2.Fac. of Life Sci.)
○Koji Yamano1, 2 , Richard J. Youle1(1.Biochemistry Section, Surgical Neurology Branch, NINDS, National Institutes of Health, USA, 2.Present address: Protein Metabolism Project, Tokyo Metropolitan Institute of Medical Science)
○Meisinger Chris(Inst. of Biochemistry, University of Freiburg, Germany)
○Ichijo Hidenori, Sekine Shiori(Lab. Cell Signal., Grad. Sch. Pharm. Sci., The Univ. of Tokyo)
○Tanaka Keiji(Tokyo Metro Ins Med Sci)
○Kurokawa Junko1, Ashihara Takashi3, Kanda Yasunari2(1.Dept Bio-info Pharmacol, MRI, Tokyo Med Dent Univ, 2.Div Pharmacol, NIHS, 3.Dept Cardiovasc Med, Shiga Univ Med Sci)
○Kanda Yasunari1, Sekino Yuko1, Furukawa Tetsushi2, Kurokawa Junko2(1.Div Pharmacol, NIHS, 2.Dept Bio-informational Pharmacol, MRI, Tokyo Med Dent Univ)
○Ishikawa Yoshihiro(Cardiovascular Research Institute, Ykohama City University School of Medicine)
○Sato Motohiko, Hayashi Hisaki, Mamun Abdullah Al, Suzuki Hiroko, Sakima Miho, Iwase Satoshi, Inukai Yoko, Nishimura Naoki, Sato Maki(Dept. of Physiology, Aichi Med. Univ.)
○Sanbe Atsushi(Dept. Pharmacothera., Schl Pharm., Iwate Medical Univ.)
○Nebigil Canan G.(University of Strasbourg, CNRS, UMR7242)
○Kurose Hitoshi, Nakaya Michio(Dep. Pharmacol. Toxicol., Grad. of Pharm. Sic, Kyushu University)
○Ozawa Takeaki(Dep. of Chem., Sch. of Sci., The Univ. of Tokyo)
○Nanbo Asuka, Ohba Yusuke(Dept. Cell Physiol., Grad. Sch. Med., Hokkaido Univ.)